MeSH D008072 - hyperlipoproteinemia type i
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Akcea Therapeutics | Volanesorsen | Waylivra | 2019-05-03 | |||
| Uniqure | Alipogene tiparvovec | Glybera | 2012-10-25 |
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
89%8/9
Phase 3
20%2/10
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use